NCT03908697

Brief Summary

•The Pilot study will involve current Marquette Method users who own and use a ClearBlue Fertility monitor and who will be asked to simultaneously use the Mira monitor for the sake of comparing the two devices to monitor the menstrual cycle.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
26

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started May 2020

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 2, 2019

Completed
7 days until next milestone

First Posted

Study publicly available on registry

April 9, 2019

Completed
1.1 years until next milestone

Study Start

First participant enrolled

May 29, 2020

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 28, 2021

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 22, 2021

Completed
Last Updated

March 24, 2025

Status Verified

March 1, 2025

Enrollment Period

9 months

First QC Date

April 2, 2019

Last Update Submit

March 21, 2025

Conditions

Outcome Measures

Primary Outcomes (3)

  • Day of the estimated beginning of the fertile phase of the menstrual cycle:

    First day of the estimated fertile phase as measured by Clearblue Fertility Monitor First day of the estimated fertile phase as measured by the MIRA Fertility Monitor

    3 months

  • Day of the estimated peak of the fertile phase of the menstrual cycle:

    Peak day of the estimated fertile phase as measured by the Clearblue Fertility Monitor Peak day of the estimated fertile phase as measured by the MIRA Fertility Monitor

    3 months

  • Day of the estimated end of the fertile phase of the menstrual cycle:

    Last day of the estimated fertile phase as measured by the Clearblue Fertility Monitor Last day of the estimated fertile phase as measured by the MIRA Fertility Monitor

    3 months

Secondary Outcomes (1)

  • Satisfaction and Ease of Use of a Electronic Fertility Monitor:

    3 months

Study Arms (1)

Single cohort

EXPERIMENTAL

All 20 participants will use ClearBlue and Mira monitors on first morning urine

Device: Mira monitor comparison to ClearBlue monitor

Interventions

Testing first morning urine with hormone test sticks at home

Single cohort

Eligibility Criteria

Age18 Years - 42 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Menstrual cycle ranging between 21-42 days
  • At least 3 cycles after cessation of breastfeeding

You may not qualify if:

  • Not currently on medications that affect ovulation and 3 months prior
  • Not currently pregnant or breastfeeding
  • No known fertility problems
  • Not planning on achieving pregnancy during the 3 menstrual cycles of the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Deer Valley family Medicine Clinic

Calgary, Alberta, T2J6W5, Canada

Location

Related Publications (5)

  • Bouchard TP, Fehring RJ, Schneider MM. Achieving Pregnancy Using Primary Care Interventions to Identify the Fertile Window. Front Med (Lausanne). 2018 Jan 9;4:250. doi: 10.3389/fmed.2017.00250. eCollection 2017.

    PMID: 29376054BACKGROUND
  • Ecochard R, Bouchard T, Leiva R, Abdulla S, Dupuis O, Duterque O, Garmier Billard M, Boehringer H, Genolini C. Characterization of hormonal profiles during the luteal phase in regularly menstruating women. Fertil Steril. 2017 Jul;108(1):175-182.e1. doi: 10.1016/j.fertnstert.2017.05.012. Epub 2017 Jun 1.

    PMID: 28579410BACKGROUND
  • Leiva RA, Bouchard TP, Abdullah SH, Ecochard R. Urinary Luteinizing Hormone Tests: Which Concentration Threshold Best Predicts Ovulation? Front Public Health. 2017 Nov 28;5:320. doi: 10.3389/fpubh.2017.00320. eCollection 2017.

    PMID: 29234665BACKGROUND
  • Direito A, Bailly S, Mariani A, Ecochard R. Relationships between the luteinizing hormone surge and other characteristics of the menstrual cycle in normally ovulating women. Fertil Steril. 2013 Jan;99(1):279-285.e3. doi: 10.1016/j.fertnstert.2012.08.047. Epub 2012 Sep 19.

    PMID: 22999798BACKGROUND
  • Severy LJ, Robinson J, Findley-Klein C, McNulty J. Acceptability of a home monitor used to aid in conception: psychosocial factors and couple dynamics. Contraception. 2006 Jan;73(1):65-71. doi: 10.1016/j.contraception.2005.07.008. Epub 2005 Sep 19.

    PMID: 16371298BACKGROUND

Related Links

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Masking Details
Anonymized demographic data
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Model Details: Prospective cohort analysis of three menstrual cycles of hormone data, comparing two fertility monitors that analyze urine hormones. Satisfaction and ease of use will be assessed using surveys. Individual data will be anonymized.
Sponsor Type
INDUSTRY
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical Lecturer

Study Record Dates

First Submitted

April 2, 2019

First Posted

April 9, 2019

Study Start

May 29, 2020

Primary Completion

February 28, 2021

Study Completion

April 22, 2021

Last Updated

March 24, 2025

Record last verified: 2025-03

Data Sharing

IPD Sharing
Will not share

Locations